Astigmatism and maternal myopia as important factors affecting success rate of DIMS lens treatment.

Patricia DomsaÉva M BankóJudit KörtvélyesChristof MeigenRita SzécheyKrisztina LantosZoltán Zsolt NagyAdrienne Csutak

Published in: BMJ open ophthalmology (2024)

In the European population, astigmatism, young age and severe maternal myopia are risk factors for suboptimal outcomes following DIMS therapy. Further research is necessary to elucidate the impact of astigmatism on myopic defocus therapy.

Keyphrases

birth weight
pregnancy outcomes
stem cells
mesenchymal stem cells
cell therapy
middle aged
gestational age
replacement therapy
cataract surgery